Studies aimed at elucidating the molecular mechanism underlying CCA are critical for identifying novel biomarkers and for improving the outcome of this fatal disease Microarray analysis of eight pairs of patients with CCA identified 47 downregulated genes including AZGP1.29 Here, AZGP1 is linked to cholangiocarcinoma.